DCB Outcomes After Plain or Scoring Balloon for Vessel Preparation in Patients With Femoropopliteal Arterial Disease

Inclusion Criteria: * Male or non-pregnant female subjects aged ≥18 years at the time of informed consent. Women of childbearing potential must have a negative pregnancy test within 7 days prior to the procedure and must agree to use a reliable method of contraception during their participation in the study. This requirement does not apply in cases of sterility, infertility, or menopause for at least 12 months. * Rutherford category 4-5. * Life expectancy \>1 year as assessed by the investigator, based on the patient's medical history. * Atherosclerotic lesions in the femoropopliteal segment, including in-stent restenosis. * The subject has been informed, understands the nature of the trial, and has signed the informed consent form to participate in the study. If the subject is capable of understanding and providing informed consent but is physically unable to sign the consent form, an impartial witness may sign on their behalf. * The patient is willing to comply with all required follow-up visits. * Presence of at least one patent infragenicular artery (with \<50% stenosis) at the end of the procedure. * Target vessel diameter ≤8 mm. Exclusion Criteria: * Pregnant women or women planning to become pregnant during the course of the study. * Participation in another investigational drug eluting technology study. * Inability to successfully cross the target lesion with a guidewire (successful crossing is defined as the guidewire tip passing through the lesion without perfora…